Structural variation at the CYP2C locus: Characterization of deletion and duplication alleles-Reference-Cited by-同舟云学术

Structural variation at the CYP2C locus: Characterization of deletion and duplication alleles

Published:2019-10-22 Issue:11 Volume:40 Page:
ISSN:1059-7794
Container-title:Human Mutation
language:en
Short-container-title:Human Mutation

Author:

Botton Mariana R.¹²,Lu Xingwu¹²,Zhao Geping²,Repnikova Elena³⁴,Seki Yoshinori²,Gaedigk Andrea⁵,Schadt Eric E.¹²,Edelmann Lisa¹²,Scott Stuart A.¹²^ORCID

Affiliation:

1. Department of Genetics and Genomic Sciences Icahn School of Medicine at Mount Sinai New York New York

2. Sema4, A Mount Sinai venture Stamford Connecticut

3. Clinical Genetics and Genomics Laboratories Children's Mercy Hospital Kansas City Kansas City Missouri

4. School of Medicine University of Missouri‐Kansas City Kansas City Missouri

5. Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation Children's Mercy Kansas City Kansas City Missouri

Funder

National Institute of General Medical Sciences

Publisher

Wiley

Subject

Genetics(clinical),Genetics

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/humu.23855

Reference60 articles.

1. Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE network

2. The impact of copy number variation on local gene expression in mouse hematopoietic stem and progenitor cells

3. Mechanisms underlying structural variant formation in genomic disorders

4. Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing

5. Glutathione-S-transferase genotypes influence the risk of chemotherapy-related toxicities and prognosis in Korean patients with diffuse large B-cell lymphoma

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of metabolism-related key genes as potential biomarkers for pathogenesis of immune thrombocytopenia;Scientific Reports;2024-04-19

2. A call for increased inclusivity and global representation in pharmacogenetic testing;npj Genomic Medicine;2024-02-22

3. Characterization of CYP2C19 pharmacogenetic variation in African populations and comparison with other global populations;Pharmacogenomics;2023-11

4. Long-read Sequencing for Germline Pharmacogenomic Testing;Advances in Molecular Pathology;2023-11

5. The Evaluation of CYP2D6, CYP2C9, CYP2C19, and CYP2B6 Phenoconversion in Post-Mortem Casework: The Challenge of Forensic Toxicogenetics;Metabolites;2023-05-16